← vers les grands investisseurs
Deep Track Capital, Lp
investisseur institutionnel · portefeuille $6.87 Md · 67 positions · rapport au 30.06.2026
Positions en Actions rapport pour 30.06.2026, déposé le 14.08.2026; modification — par rapport à 31.03.2026 · 66
| Société | Actions | Valeur | % du portefeuille | Variation sur le Trimestre |
|---|---|---|---|---|
| Guardant Health Inc US:GH | 3 393 312 | $509 M | 7.50% | nouvelle |
| Immunovant, Inc. US:IMVT | 9 341 151 | $360 M | 5.30% | nouvelle |
| Structure Therapeutics Inc.… US:GPCR | 4 740 072 | $254 M | 3.75% | nouvelle |
| Vaxcyte Inc US:PCVX | 4 300 000 | $250 M | 3.68% | nouvelle |
| Alnylam Pharmaceuticals Inc US:ALNY | 825 000 | $248 M | 3.66% | nouvelle |
| Veradermics, Incorporated US:MANE | 2 000 000 | $246 M | 3.62% | nouvelle |
| Tarsus Pharmaceuticals Inc US:TARS | 3 666 768 | $231 M | 3.40% | nouvelle |
| NUVALENT INC CUSIP 670703107 | 1 783 322 | $220 M | 3.24% | nouvelle |
| ALKERMES PLC CUSIP G01767105 | 4 000 000 | $210 M | 3.09% | nouvelle |
| Ocular Therapeutix Inc US:OCUL | 19 686 282 | $193 M | 2.85% | nouvelle |
| Biomarin Pharmaceutical Inc US:BMRN | 3 307 481 | $189 M | 2.79% | nouvelle |
| Nurix Therapeutics Inc US:NRIX | 7 736 455 | $188 M | 2.76% | nouvelle |
| Oruka Therapeutics, Inc. US:ORKA | 1 926 000 | $183 M | 2.70% | nouvelle |
| Alumis Inc US:ALMS | 6 348 558 | $179 M | 2.63% | nouvelle |
| Ionis Pharmaceuticals Inc US:IONS | 2 200 000 | $174 M | 2.57% | nouvelle |
| Compass Pathways Plc US:CMPS | 12 161 496 | $172 M | 2.54% | nouvelle |
| Vera Therapeutics Inc US:VERA | 4 000 000 | $172 M | 2.53% | nouvelle |
| Axsome Therapeutics Inc US:AXSM | 700 000 | $171 M | 2.52% | nouvelle |
| Genmab A/S US:GMAB | 5 650 000 | $155 M | 2.29% | nouvelle |
| MoonLake Immunotherapeutics US:MLTX | 6 999 025 | $136 M | 2.01% | nouvelle |
| Hemab Therapeutics Holdings,… US:COAG | 3 602 093 | $132 M | 1.95% | nouvelle |
| Tango Therapeutics, Inc. US:TNGX | 4 200 000 | $131 M | 1.93% | nouvelle |
| Definium Therapeutics, Inc. US:DFTX | 2 750 000 | $129 M | 1.91% | nouvelle |
| GRAIL, LLC US:GRAL | 1 834 944 | $125 M | 1.85% | nouvelle |
| Bicara Therapeutics Inc. US:BCAX | 4 100 000 | $122 M | 1.79% | nouvelle |
| Maze Therapeutics, Inc. US:MAZE | 3 732 569 | $111 M | 1.64% | nouvelle |
| Celldex Therapeutics Inc US:CLDX | 2 939 151 | $109 M | 1.61% | nouvelle |
| LB PHARMACEUTICALS INC US:LBRX | 3 352 804 | $109 M | 1.60% | nouvelle |
| MBX Biosciences, Inc. US:MBX | 1 732 569 | $95.6 M | 1.41% | nouvelle |
| GH RESEARCH PLC CUSIP G3855L106 | 3 333 334 | $89.6 M | 1.32% | nouvelle |
| Cogent Biosciences Inc US:COGT | 2 000 000 | $77.4 M | 1.14% | nouvelle |
| ATAIBECKLEY INC CUSIP 04650F101 | 14 417 442 | $76.0 M | 1.12% | nouvelle |
| UNITED THERAPEUTICS Corp US:UTHR | 123 616 | $67.0 M | 0.99% | nouvelle |
| Avalo Therapeutics Inc US:AVTX | 3 610 000 | $66.7 M | 0.98% | nouvelle |
| Viridian Therapeutics Inc US:VRDN | 3 592 740 | $66.0 M | 0.97% | nouvelle |
| Cytokinetics Inc US:CYTK | 700 000 | $59.6 M | 0.88% | nouvelle |
| Altimmune Inc US:ALT | 19 250 000 | $58.5 M | 0.86% | nouvelle |
| Personalis Inc US:PSNL | 4 000 000 | $53.6 M | 0.79% | nouvelle |
| Aclaris Therapeutics Inc US:ACRS | 9 345 000 | $49.4 M | 0.73% | nouvelle |
| CorMedix Inc US:CRMD | 6 274 076 | $49.3 M | 0.73% | nouvelle |
| GeneDx Holdings Corp. US:WGS | 700 000 | $48.1 M | 0.71% | nouvelle |
| Harrow Health Inc US:HROW | 969 000 | $41.2 M | 0.61% | nouvelle |
| Corvus Pharmaceuticals Inc US:CRVS | 2 491 939 | $37.2 M | 0.55% | nouvelle |
| Solid Biosciences LLC US:SLDB | 3 565 062 | $35.6 M | 0.52% | nouvelle |
| Beam Therapeutics Inc. US:BEAM | 1 000 000 | $34.3 M | 0.51% | nouvelle |
| Dyne Therapeutics Inc US:DYN | 1 500 000 | $33.3 M | 0.49% | nouvelle |
| Immix Biopharma Inc US:IMMX | 2 775 000 | $28.6 M | 0.42% | nouvelle |
| X4 Pharmaceuticals Inc US:XFOR | 5 878 757 | $27.5 M | 0.40% | nouvelle |
| Shattuck Labs Inc US:STTK | 3 706 734 | $25.7 M | 0.38% | nouvelle |
| MannKind Corp US:MNKD | 6 000 000 | $25.6 M | 0.38% | nouvelle |
| Century Therapeutics Inc US:IPSC | 9 462 645 | $23.2 M | 0.34% | nouvelle |
| Generate Biomedicines, Inc. US:GENB | 1 333 815 | $22.5 M | 0.33% | nouvelle |
| Verastem Inc US:VSTM | 5 740 850 | $21.9 M | 0.32% | nouvelle |
| Kura Oncology, Inc. US:KURA | 1 978 565 | $21.7 M | 0.32% | nouvelle |
| Enanta Pharmaceuticals Inc US:ENTA | 1 444 167 | $21.1 M | 0.31% | nouvelle |
| NEKTAR THERAPEUTICS US:NKTR | 300 000 | $20.9 M | 0.31% | nouvelle |
| Olema Pharmaceuticals Inc US:OLMA | 1 500 000 | $18.8 M | 0.28% | nouvelle |
| Kailera Therapeutics, Inc. US:KLRA | 700 000 | $15.4 M | 0.23% | nouvelle |
| Kardigan, Inc. US:KARD | 600 000 | $14.3 M | 0.21% | nouvelle |
| Enliven Therapeutics Inc. US:ELVN | 225 000 | $11.4 M | 0.17% | nouvelle |
| ProMIS Neurosciences Inc. US:PMN | 835 655 | $11.0 M | 0.16% | nouvelle |
| Immunocore Holdings Ltd US:IMCR | 311 218 | $9.88 M | 0.15% | nouvelle |
| Xencor Inc US:XNCR | 593 551 | $9.56 M | 0.14% | nouvelle |
| Context Therapeutics Inc US:CNTX | 7 419 355 | $4.11 M | 0.06% | nouvelle |
| INVENTIVA US:IVA | 800 000 | $3.02 M | 0.04% | nouvelle |
| Aligos Therapeutics Inc US:ALGS | 444 110 | $2.56 M | 0.04% | nouvelle |
Dans les entreprises de notre base de données 8
| Société | Participation | Actions | Date du Rapport |
|---|---|---|---|
| Aclaris Therapeutics Inc | 6.68% | 9 345 000 | 2026-06-30 |
| Verastem Inc | 6.34% | 5 740 850 | 2026-06-30 |
| GH Research PLC | 4.86% | 3 333 334 | 2026-06-30 |
| Viridian Therapeutics Inc | 3.17% | 3 592 740 | 2026-06-30 |
| Vaxcyte Inc | 2.89% | 4 300 000 | 2026-06-30 |
| Alkermes Plc | 2.38% | 4 000 000 | 2026-06-30 |
| Axsome Therapeutics Inc | 1.34% | 700 000 | 2026-06-30 |
| Genmab A/S | 0.91% | 5 650 000 | 2026-06-30 |
publicité